Health Secretary Robert F. Kennedy, Jr. discusses upcoming 4-page dietary guidelines directing Americans to 'eat whole food' with major reforms, promising an early release before August.
A systematic review reveals that GLP-1 receptor agonists not only address psychotropic-induced metabolic disorders but also may positively impact mental wellbeing.
A minimally invasive procedure using electrical pulses in the small intestine shows promise in significantly improving type 2 diabetes, with benefits rivaling gastric bypass surgery.
April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.